Allen & Overy (A&O) and Slaughter and May are among a line-up of top law firms advising on Japanese pharma group Shionogi's purchase of a 10% stake in Pfizer and GlaxoSmithKline's (GSK) joint venture ViiV Healthcare.
November 08, 2012 at 07:03 PM
1 minute read
The original version of this story was published on Legalweek
Allen & Overy (A&O) and Slaughter and May are among a line-up of top law firms advising on Japanese pharma group Shionogi’s purchase of a 10% stake in Pfizer and GlaxoSmithKline’s (GSK) joint venture ViiV Healthcare.
The HIV and AIDS venture, formed in 2009, is 85% owned by GSK, with Pfizer holding the other 15%. Shionogi’s purchase will see those stakes fall to 76.5% and 13.5% respectively. Financial terms of the deal were not disclosed.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
The premier educational and networking event for employee benefits brokers and agents.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
